1. Home
  2. ECPG vs NXPLW Comparison

ECPG vs NXPLW Comparison

Compare ECPG & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECPG
  • NXPLW
  • Stock Information
  • Founded
  • ECPG 1998
  • NXPLW N/A
  • Country
  • ECPG United States
  • NXPLW United States
  • Employees
  • ECPG N/A
  • NXPLW 166
  • Industry
  • ECPG Finance Companies
  • NXPLW Telecommunications Equipment
  • Sector
  • ECPG Finance
  • NXPLW Telecommunications
  • Exchange
  • ECPG Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • ECPG N/A
  • NXPLW N/A
  • IPO Year
  • ECPG 1999
  • NXPLW N/A
  • Fundamental
  • Price
  • ECPG $30.41
  • NXPLW N/A
  • Analyst Decision
  • ECPG Strong Buy
  • NXPLW
  • Analyst Count
  • ECPG 3
  • NXPLW 0
  • Target Price
  • ECPG $62.67
  • NXPLW N/A
  • AVG Volume (30 Days)
  • ECPG 332.6K
  • NXPLW 6.4K
  • Earning Date
  • ECPG 05-07-2025
  • NXPLW 03-31-2025
  • Dividend Yield
  • ECPG N/A
  • NXPLW N/A
  • EPS Growth
  • ECPG N/A
  • NXPLW N/A
  • EPS
  • ECPG N/A
  • NXPLW N/A
  • Revenue
  • ECPG $1,316,361,000.00
  • NXPLW $66,482,000.00
  • Revenue This Year
  • ECPG $21.62
  • NXPLW N/A
  • Revenue Next Year
  • ECPG $10.12
  • NXPLW N/A
  • P/E Ratio
  • ECPG N/A
  • NXPLW N/A
  • Revenue Growth
  • ECPG 7.66
  • NXPLW 179.89
  • 52 Week Low
  • ECPG $26.45
  • NXPLW $0.25
  • 52 Week High
  • ECPG $51.77
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • ECPG 40.91
  • NXPLW N/A
  • Support Level
  • ECPG $28.93
  • NXPLW N/A
  • Resistance Level
  • ECPG $30.99
  • NXPLW N/A
  • Average True Range (ATR)
  • ECPG 2.24
  • NXPLW 0.00
  • MACD
  • ECPG 0.15
  • NXPLW 0.00
  • Stochastic Oscillator
  • ECPG 41.77
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: